I
Iterative Health
Health Tech & Medtech · Boston, United States · Founded 2017
Computer vision tools for gastroenterologists MoreLess
Iterative Scopes is a startup that operates in the healthcare sector, specifically focusing on Gastrointestinal (GI) care. The company leverages the power of artificial intelligence (AI) and machine learning (ML) to enhance the precision and effectiveness of GI treatments. Its primary aim is to provide world-class care and treatment to patients globally, with a particular focus on colorectal cancer prevention and diagnosis.
The company's business model revolves around the development and deployment of AI and ML technologies in the healthcare sector. One of their key products is SKOUT®, an FDA cleared polyp detection device that aids physicians in detecting adenomas, a precursor to colorectal cancer. This device does not replace physician judgment but enhances it, leading to more accurate diagnoses.
Iterative Scopes also offers services and technology that optimize clinical trials, maximizing the value of clinical research practices. This is achieved through their AI-enabled documentation technology, which improves the quality and continuity of patient care. The technology also allows for standardized, high-quality reporting across institutions, making high-standard care accessible to previously underserved populations.
The company's revenue is likely generated through the sale of their AI and ML technologies and services to healthcare institutions and professionals. They also potentially earn from partnerships with research institutions and pharmaceutical companies for clinical trial optimization.
Keywords: Healthcare, Gastrointestinal Care, Artificial Intelligence, Machine Learning, Colorectal Cancer, Clinical Trial Optimization, SKOUT®, Adenoma Detection, AI-Enabled Documentation, Underserved Populations.
Talent graph
Iterative Health's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Iterative Health has talent and traffic
team presence
across markets
Patent intelligence
$854k patent portfolio · 6 active families
Where Iterative Health concentrates vs peers
Each axis is a top-10 topic across Iterative Health and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Iterative Health
An AI-synthesized read of the highest-engagement posts about Iterative Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Iterative Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.













